Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Stitch Fix Inc (SFIX) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

Stitch Fix IncTrade
DENTSPLY SIRONA IncTrade

Price performance (Past 24H)

Key statistics

Stitch Fix Inc vs DENTSPLY SIRONA Inc — how do they compare? Stitch Fix Inc trades at $2.74 (market cap $366.07M), while DENTSPLY SIRONA Inc trades at $8.67 (market cap $1.73B). The key difference: DENTSPLY SIRONA Inc is far larger — about 4.7× Stitch Fix Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Stitch Fix Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Stitch Fix Inc for 31 Days and DENTSPLY SIRONA Inc for 72 Days on average.

SFIXXRAY
Market Cap
$366.07M$1.73B
Volume
5,152,0086,198,582
Sector
Consumer CyclicalHealth
52-Week High
$5.64$14.68
52-Week Low
$2.16$8.52
Typical Hold Time
31 Days72 Days
Enterprise Value
$261.88M$3.80B
Dividend Yield
—5.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Stitch Fix Inc

Stitch Fix (SFIX) trades at $2.73, up 2.25% today, but remains under pressure with a bearish technical signal. Recent Q4 2026 earnings showed a narrower loss than expected, but revenue missed estimates and weak FY2027 guidance triggered an 18% stock drop. The company is navigating a challenging consumer environment while leveraging AI personalization to boost engagement. Fundamentals show improving net loss margins, but negative ROE and ROA persist.

The outlook is cautious. While cost controls are improving losses, declining active clients and soft revenue guidance pose headwinds. Analyst consensus is a $3.40 price target with a 'Hold' bias. Key risks include execution on growth initiatives, high client acquisition costs, and ongoing legal investigations. The stock offers speculative appeal if turnaround gains traction, but near-term volatility is likely.

DENTSPLY SIRONA Inc

DENTSPLY SIRONA (XRAY) trades at $8.54, near a 52-week low, with a bearish technical signal from moving averages. The company reported a Q2 2026 earnings beat but faces declining revenues and negative net income margins. Recent news highlights institutional stake increases and ongoing turnaround efforts amid sales weakness in dental segments.

The outlook remains challenging due to persistent profitability issues and high debt, though analyst consensus suggests upside to a $13.40 price target. Key risks include margin pressure and competitive threats, while potential catalysts include successful restructuring and digital dentistry growth.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SFIX
0% Buy100% Sell
Avg holding period · 31 Days
XRAY

No sentiment data available yet.

Top news

Latest headlines on both assets

About Stitch Fix Inc

Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.

Read more on SFIX →

About DENTSPLY SIRONA Inc

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters

Read more on XRAY →